Nordic Trial Alliance (NTA)
Over the past decade there has been a significant decrease in clinical trials in the Nordic countries. This has a highly negative impact on the Nordic health sector, with potentially dramatic consequences. Some of these consequences are:
- delays before new methods and treatments are introduced to patients
- clinical trials that cannot deliver conclusive data and therefore must be repeated
- the redirection of multinational trial proposals to other areas of the world
Greater coordination to increase access to research infrastructures and ensure sharing of competencies and resources is required if Nordic clinical research is to maintain its strong foothold and international position. Nordic collaboration is needed between companies, hospitals and universities to achieve this goal. This is the background for establishing NTA.
The Nordic Trial Alliance pilot project started in 2013.
Read more on the NTA website